SGUI Financials 07/15/2014 23:18:39 Sanguine Corp
Post# of 4
Sanguine Corp.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - 33
Cost of Revenue - 18
Gross Profit - 15
Operating Expenses
Research and Development 18 -
Sales, General and Admin. 1,362 421
Non-Recurring Items - -
Other - -
Operating Income (1,379) (406)
Income From Continuing Operations
Add'l Income/Expense Items (2) 85
Earnings Before Interest and Tax (1,381) (321)
Interest Expense 25 12
Earnings Before Tax (1,405) (333)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (1,407) (256)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (1,405) (333)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (1,405) (333)